Skip to content
Founder TaxPartners

EMI vs Unapproved Options Calculator 2026/27

Enter the option terms and exit value. The tool compares the employee tax cost and the company National Insurance cost across EMI, unapproved options and growth shares at 2026/27 rates. All outputs are general guidance; speak to a specialist before granting or exercising options.

Calculator

EMI vs Unapproved Options Calculator 2026/27

Enter the option terms and exit value. The tool compares the employee tax cost and the company National Insurance cost across EMI, unapproved options and growth shares at 2026/27 rates. All outputs are general guidance; speak to a specialist before granting or exercising options.

£

The agreed actual market value per share (or per the whole grant) at the date of grant. Used as the EMI base cost and the growth-share starting point.

£

What the employee pays to exercise. For a clean EMI grant, this equals AMV. If below AMV, EMI still produces an income tax charge on the discount.

£

Value of the shares at sale or exit. Unapproved column assumes exercise and sale happen together (cashless exercise). For EMI, this is the disposal proceeds.

Sets where income tax on the unapproved exercise charge starts (20%, 40% or 45%, rising through the bands as the gain grows), and whether CGT starts at 18% (basic rate) or is 24% throughout (higher and additional rate).

£

The unrestricted market value of the growth shares when the employee gets them (usually a low hope value). Defaults to 0. With a s.431 election made within 14 days, income tax at acquisition is on this value less what the employee pays.

£

What the employee pays for the growth shares. Paying the full market value means there's no income tax at acquisition.

EMI vs unapproved: employee tax saving
£30,284
EMI employee tax £18,000 vs unapproved employee tax £48,284 (income tax + est. employee NIC)
EMI: income tax at exerciseNil (exercise price at or above the market value at grant)
EMI: CGT at sale (18% BADR (2-yr rule))£18,000
EMI: employer NIC cost to companyNil (no employment income charge on exercise)
EMI: total employee tax£18,000
Unapproved: income tax at exercise (40% to £125,140, 45% above, personal allowance tapered)£46,284
Unapproved: employee NIC estimate£2,000
Unapproved: employer NIC cost to company (15%)£15,000
Unapproved: total employee tax (inc. NIC)£48,284
Growth shares: income tax at acquisition (s.431)Nil (zero acquisition value)
Growth shares: CGT at exit (24%, no auto-BADR)£24,000
Growth shares: employer NIC cost to companyNil
Growth shares: total employee tax£24,000

Unapproved column assumes exercise at exit (cashless); income tax applies on the full gain at exercise and post-exercise CGT is nil. Employee NIC uses the same assumption as income tax: for a basic-rate employee, 8% on the first £37,700 and 2% above; for higher and additional-rate employees, 2% throughout. NIC is due on an option gain only where the shares are readily convertible assets at exercise, as they usually are when you exercise on an exit. Employer NIC of £15,000 is modelled as a flat 15% of the option gain; the £5,000 secondary threshold is annual/per-employee, not per-grant, and is not deducted here. Growth shares require a s.431 election within 14 days of acquisition and an independent valuation at issue (HMRC doesn't agree growth share values in advance); income tax at acquisition is on the market value less what the employee pays, so it's nil if they pay full value. BADR is not automatic on growth shares or shares from unapproved options: they need the usual 5% tests, held for 2 years, while EMI shares qualify without the 5% test. With BADR on, the 18% rate is applied to the first £1m of the EMI gain (the lifetime limit, assuming none of it has been used on an earlier disposal) and 24% CGT to any gain above that, because the BADR gain uses up the basic-rate band first. From 6 April 2027 the lifetime limit is due to fall from £1 million to £500,000 (announced at Budget 2026, still to pass in the Finance Bill). For a basic-rate employee the CGT figures assume the whole £37,700 basic-rate band is unused, so 18% covers at most the first £37,700 of a gain and the rest is at 24%; if salary or other income uses part of the band, more of the gain is at 24%. The £3,000 annual exempt amount is not deducted. Income tax (on the unapproved exercise, the growth-share acquisition and any EMI discount) uses the same assumption: the amount sits on top of your other income from the bottom of the band you selected, with the whole of that band unused. For a basic-rate employee that is 20% on the first £37,700, 40% up to £125,140 of taxable income and 45% above; for a higher-rate employee, 40% up to £125,140 and 45% above; for an additional-rate employee, 45% throughout. Where the amount takes your income over £100,000, the personal allowance falls by £1 for every £2 over, and the income tax figures include that. Where the EMI exercise price is below the market value at grant, the discount taxed as income is added to the cost of the shares for CGT, so the EMI gain is measured from that market value and the discount is not taxed twice. The discount also carries employee NIC and 15% employer NIC where the shares are readily convertible at exercise. These figures are general guidance only; qualifying-company questions and actual grant structuring require specialist advice.

Check your position with a startup tax specialist

A calculator gives you the shape of the answer. We confirm your exact figures, the reliefs you can claim, and what your business needs to file. No obligation, and we reply within 24 hours.

We'll only use your details to respond to your enquiry. We don't pass them to any other firm. See our Privacy Policy.

EMI vs unapproved options vs growth shares: the tax difference explained

Enterprise Management Incentives (EMI) are the tax-advantaged option route built for qualifying UK startups: for options granted from 6 April 2026, the company needs gross assets of £120 million or less and fewer than 500 full-time equivalent employees, and it can have up to £6 million of unexercised options. There's no income tax at grant and no income tax at exercise provided the exercise price equals or exceeds the actual market value at grant (you can agree that value with HMRC first, but it's voluntary). The gain from exercise price to exit is subject only to Capital Gains Tax, and if the option was granted at least two years before the sale, Business Asset Disposal Relief applies at 18% with no need to pass the 5% personal-company test. That rate covers gains up to the £1m lifetime limit; any gain above it is taxed at 24%, because the BADR gain uses up the basic-rate band first. From 6 April 2027 the lifetime limit is due to fall from £1 million to £500,000 (announced at Budget 2026, still to pass in the Finance Bill). The company also pays no employer NIC on a clean EMI exercise, because there is no employment income charge.

The difference between approved and unapproved options is simply whether the options sit inside a tax-advantaged scheme: 'approved' is the informal name for options under a tax-advantaged scheme such as EMI or CSOP (which HMRC now also calls EMI2), and unapproved options are any granted outside them, so they get none of the reliefs. Under general employment-related-securities rules, the difference between market value and exercise price is charged to income tax at exercise, as employment income, with employee NIC and 15% employer NIC on the same amount where the shares are readily convertible assets, as they usually are on an exit. For a higher-rate taxpayer that's 40% income tax or more (45% on the slice over £125,140, and the personal allowance tapers away between £100,000 and £125,140) plus employee NIC, against an 18% CGT charge under EMI: a substantial difference on the same economic gain.

Growth shares are shares rather than options, usually in a new class that only participates in exit proceeds above a hurdle. They are acquired up front at a low hope-value; with a section 431 election made within 14 days, the employee is taxed on the unrestricted market value at acquisition (often very low) less anything they pay for the shares, so there's no income tax if they pay full value, and future growth to exit is CGT rather than income tax. Standard CGT rates apply (18% on any part of the gain that fits in your unused basic-rate band, 24% above it), not the EMI-specific BADR treatment. Growth shares need an independent valuation at issue and the s.431 election to work correctly.

The calculator models the unapproved column under the cashless-exercise assumption (exercise and sale happen together). In practice, unapproved options exercised before exit would produce income tax at exercise on the then-market-value, with further CGT on any later gain. The headline comparison holds directionally but the exact split differs with timing.

Frequently asked questions

18% on qualifying gains up to the £1m lifetime limit. From 6 April 2027 the lifetime limit is due to fall from £1 million to £500,000 (announced at Budget 2026, still to pass in the Finance Bill). EMI shares qualify for BADR under the two-year holding rule from grant without needing to pass the 5% personal-company test that applies to other shares.

Yes, provided the option was granted at least two years before you sell and you've been an officer or employee of the company (or another group company) throughout those two years. The 5% personal-company test that normally applies to BADR is waived for EMI shares. The company and the options must still qualify under the EMI rules.

Income tax at the employee's marginal rate on the difference between market value and exercise price, plus employee NIC under the primary Class 1 rules (8% between £12,570 and £50,270, 2% above). The company also pays employer NIC at 15% on the same amount. The NIC applies where the shares are readily convertible assets at exercise, as they usually are when you exercise on an exit.

15% of the option gain (the amount charged to income tax at exercise), where the shares are readily convertible assets at exercise. This is a company cost, not an employee cost. A clean EMI exercise at AMV is not earnings, so no employer NIC arises on EMI; if the exercise price is below the market value at grant, the 15% applies to that discount.

Growth shares are a new class of shares that only participate in exit proceeds above a hurdle value. With a section 431 election within 14 days of acquisition, income tax at acquisition is charged on the low hope-value less anything paid for the shares; subsequent growth to exit is taxed as CGT at 18% on any part that fits in the unused basic-rate band and 24% above it. BADR does not apply automatically to growth shares.

A joint election under section 431 ITEPA 2003 on restricted securities (including growth shares). It must be made within 14 days of acquiring the shares. It elects for income tax at acquisition to be charged on the unrestricted market value, locking in CGT treatment for future growth. Missing the 14-day window is a classic funded-startup trap.

EMI is almost always cheaper for the company. On a clean EMI exercise (exercise price at AMV), no employer NIC arises. On an unapproved option exercise, the company pays 15% employer NIC on the full gain where the shares are readily convertible. On a £100,000 gain that is £15,000 of company cash.

Tell us about your startup situation and we will confirm your exact figures and the compliance steps that apply to you. No obligation.

We'll only use your details to respond to your enquiry. We don't pass them to any other firm. See our Privacy Policy.